Form D · Hedge Fund

BioImpact Equities Fund, LP

Boston, MA · CIK 0001807882

Offering snapshot reported Mar 10, 2026 · SEC filing

Reported sold
$125M
Indefinite offering
Investors reported
93
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 1, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$62.7M$125MApr 26, 2021: $71,340,958.00Apr 26, 2021Dec 21, 2021: $72,440,958.00Mar 8, 2023: $76,926,307.00Mar 8, 2023Mar 8, 2024: $90,090,958.00Mar 8, 2024Mar 10, 2025: $109,495,043.00Mar 10, 2025Mar 10, 2026: $125,453,844.00Mar 10, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$76,926,307 → $125,453,844
  • Reported investors47 → 93

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 10, 2026Amendment$125,453,844$48,527,537vs Mar 8, 202393SEC filing
Mar 10, 2025Amendment$109,495,043$32,568,736vs Mar 8, 202379SEC filing
Mar 8, 2024Amendment$90,090,958$13,164,651vs Mar 8, 202354SEC filing
Mar 8, 2023Amendment$76,926,307$4,485,349vs Dec 21, 202147SEC filing
Dec 21, 2021Amendment$72,440,958$1,100,000vs Apr 26, 202143SEC filing
Apr 26, 2021Amendment$71,340,958No comparisonNot reportedSEC filing
Mar 27, 2020Initial$58,449,819No comparison33SEC filing

Offering details

Securities
Pooled investment fund, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-363866
The total amount sold and number of investors reflect only sales to residents of the U.S. and do not take redemptions and/or withdrawals into consideration.
Limited Partnership Interests. The General Partner, in its sole and absolute discretion, may accept investments of less than the $1,000,000 minimum.

Source: Form D, filed Mar 10, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BIOIMPACT EQUITIES FUND, LP

Investment adviser: MPM ASSET MANAGEMENT LLC

Gross asset value
$312M
Beneficial owners
70
ADV minimum commitment
$1M

Reported in Form ADV on Apr 28, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SS&C TECHNOLOGIES, INC. BOSTON, Massachusetts, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG BOSTON, Massachusetts, United States
Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian JP MORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No
Prime broker JEFFERIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 185

JEFFERIES LLC
SEC 8-15074

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Filing source

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1), fund 805-1135587442

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christiana Goh Bardon Executive
N/A Bio Impact Equities Llc Executive
N/A Burrage Capital, Llc Executive
Kristen Laguerre Executive
Howard B. Rubin Executive
Christopher Wolf Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
399 Boylston Street, Suite 1100
Boston, MA, 02116